Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Budding trends in integrated pest management using advanced micro- and nano-materials: Challenges and perspectives.

Khandelwal N, Barbole RS, Banerjee SS, Chate GP, Biradar AV, Khandare JJ, Giri AP.

J Environ Manage. 2016 Dec 15;184(Pt 2):157-169. doi: 10.1016/j.jenvman.2016.09.071. Epub 2016 Sep 30. Review.

PMID:
27697374
2.

Bio-physical evaluation and in vivo delivery of plant proteinase inhibitor immobilized on silica nanospheres.

Khandelwal N, Doke DS, Khandare JJ, Jawale PV, Biradar AV, Giri AP.

Colloids Surf B Biointerfaces. 2015 Jun 1;130:84-92. doi: 10.1016/j.colsurfb.2015.03.060. Epub 2015 Apr 8.

PMID:
25909183
3.

Self-propelled carbon nanotube based microrockets for rapid capture and isolation of circulating tumor cells.

Banerjee SS, Jalota-Badhwar A, Zope KR, Todkar KJ, Mascarenhas RR, Chate GP, Khutale GV, Bharde A, Calderon M, Khandare JJ.

Nanoscale. 2015 May 21;7(19):8684-8. doi: 10.1039/c5nr01797a.

PMID:
25902947
4.

Biophysical interactions of polyamidoamine dendrimer coordinated Fe3O4 nanoparticles with insulin.

Samant M, Banerjee SS, Taneja N, Zope K, Ghogale P, Khandare JJ.

J Biomed Nanotechnol. 2014 Jul;10(7):1286-93.

PMID:
24804549
5.

Transferrin-mediated rapid targeting, isolation, and detection of circulating tumor cells by multifunctional magneto-dendritic nanosystem.

Banerjee SS, Jalota-Badhwar A, Satavalekar SD, Bhansali SG, Aher ND, Mascarenhas RR, Paul D, Sharma S, Khandare JJ.

Adv Healthc Mater. 2013 Jun;2(6):800-5. doi: 10.1002/adhm.201200164. Epub 2012 Nov 1.

PMID:
23184885
6.

Design, synthesis and evaluation of N-acetyl glucosamine (NAG)-PEG-doxorubicin targeted conjugates for anticancer delivery.

Pawar SK, Badhwar AJ, Kharas F, Khandare JJ, Vavia PR.

Int J Pharm. 2012 Oct 15;436(1-2):183-93. doi: 10.1016/j.ijpharm.2012.05.078. Epub 2012 Jun 18.

PMID:
22721850
7.

PEG-conjugated highly dispersive multifunctional magnetic multi-walled carbon nanotubes for cellular imaging.

Khandare JJ, Jalota-Badhwar A, Satavalekar SD, Bhansali SG, Aher ND, Kharas F, Banerjee SS.

Nanoscale. 2012 Feb 7;4(3):837-44. doi: 10.1039/c1nr11540e. Epub 2011 Dec 15.

PMID:
22170574
8.

Multifunctional tumor-targeted polymer-peptide-drug delivery system for treatment of primary and metastatic cancers.

Chandna P, Khandare JJ, Ber E, Rodriguez-Rodriguez L, Minko T.

Pharm Res. 2010 Nov;27(11):2296-306. doi: 10.1007/s11095-010-0235-2. Epub 2010 Aug 11.

PMID:
20700631
9.

LHRH-targeted nanoparticles for cancer therapeutics.

Minko T, Patil ML, Zhang M, Khandare JJ, Saad M, Chandna P, Taratula O.

Methods Mol Biol. 2010;624:281-94. doi: 10.1007/978-1-60761-609-2_19.

PMID:
20217603
10.

Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?

Saad M, Garbuzenko OB, Ber E, Chandna P, Khandare JJ, Pozharov VP, Minko T.

J Control Release. 2008 Sep 10;130(2):107-14. doi: 10.1016/j.jconrel.2008.05.024. Epub 2008 Jun 25.

11.

Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor.

Wang Y, Saad M, Pakunlu RI, Khandare JJ, Garbuzenko OB, Vetcher AA, Soldatenkov VA, Pozharov VP, Minko T.

Clin Cancer Res. 2008 Jun 1;14(11):3607-16. doi: 10.1158/1078-0432.CCR-07-2020.

12.

Targeted sialic acid-doxorubicin prodrugs for intracellular delivery and cancer treatment.

Jayant S, Khandare JJ, Wang Y, Singh AP, Vorsa N, Minko T.

Pharm Res. 2007 Nov;24(11):2120-30. Epub 2007 Aug 1.

PMID:
17668297
13.

Antibodies and peptides in cancer therapy.

Khandare JJ, Minko T.

Crit Rev Ther Drug Carrier Syst. 2006;23(5):401-35. Review.

PMID:
17425513
14.

Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel.

Khandare JJ, Jayant S, Singh A, Chandna P, Wang Y, Vorsa N, Minko T.

Bioconjug Chem. 2006 Nov-Dec;17(6):1464-72.

PMID:
17105225
15.

New generation of liposomal drugs for cancer.

Minko T, Pakunlu RI, Wang Y, Khandare JJ, Saad M.

Anticancer Agents Med Chem. 2006 Nov;6(6):537-52. Review.

PMID:
17100558
16.

In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug.

Pakunlu RI, Wang Y, Saad M, Khandare JJ, Starovoytov V, Minko T.

J Control Release. 2006 Aug 28;114(2):153-62. Epub 2006 Jun 15.

PMID:
16889867
17.

JNK1 as a molecular target to limit cellular mortality under hypoxia.

Betigeri S, Pakunlu RI, Wang Y, Khandare JJ, Minko T.

Mol Pharm. 2006 Jul-Aug;3(4):424-30.

PMID:
16889436
18.

Novel polymeric prodrug with multivalent components for cancer therapy.

Khandare JJ, Chandna P, Wang Y, Pozharov VP, Minko T.

J Pharmacol Exp Ther. 2006 Jun;317(3):929-37. Epub 2006 Feb 9.

PMID:
16469865
19.

Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy.

Dharap SS, Chandna P, Wang Y, Khandare JJ, Qiu B, Stein S, Minko T.

J Pharmacol Exp Ther. 2006 Mar;316(3):992-8. Epub 2005 Nov 15.

PMID:
16291730
20.

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

Dharap SS, Wang Y, Chandna P, Khandare JJ, Qiu B, Gunaseelan S, Sinko PJ, Stein S, Farmanfarmaian A, Minko T.

Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12962-7. Epub 2005 Aug 25.

Supplemental Content

Loading ...
Support Center